.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Best-practice recommendations for autoimmune encephalitis emphasize that diagnosis is clinical and should not wait for antibody results when the syndrome is strongly suggestive. New-onset seizures, psychiatric symptoms, cognitive change, movement disorders or autonomic instability can occur in different combinations, and MRI and EEG help identify supportive patterns while cerebrospinal-fluid analysis helps assess inflammatory and infectious alternatives. The guidance recommends considering empiric immunotherapy when clinical suspicion is high after appropriate exclusion of major mimics. For internists and neurologists, the challenge is balancing urgency with diagnostic discipline. Infectious encephalitis, metabolic disorders, toxic exposures and neoplastic processes may present similarly, and indiscriminate immunosuppression can be harmful. The publication therefore provides a practical framework for sequencing investigations, involving neurology early and screening for an associated tumor when the phenotype warrants it. First-line immunotherapy commonly includes corticosteroids with or without IVIG or plasma exchange, while second-line therapy may be considered when there is inadequate response. The key teaching point is that timely recognition matters because delay in treatment can worsen neurologic outcomes.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Best-practice recommendations for autoimmune encephalitis emphasize that diagnosis is clinical and should not wait for antibody results when the syndrome is strongly suggestive. New-onset seizures, psychiatric symptoms, cognitive change, movement disorders or autonomic instability can occur in different combinations, and MRI and EEG help identify supportive patterns while cerebrospinal-fluid analysis helps assess inflammatory and infectious alternatives. The guidance recommends considering empiric immunotherapy when clinical suspicion is high after appropriate exclusion of major mimics. For internists and neurologists, the challenge is balancing urgency with diagnostic discipline. Infectious encephalitis, metabolic disorders, toxic exposures and neoplastic processes may present similarly, and indiscriminate immunosuppression can be harmful. The publication therefore provides a practical framework for sequencing investigations, involving neurology early and screening for an associated tumor when the phenotype warrants it. First-line immunotherapy commonly includes corticosteroids with or without IVIG or plasma exchange, while second-line therapy may be considered when there is inadequate response. The key teaching point is that timely recognition matters because delay in treatment can worsen neurologic outcomes.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
